Clinical Trial

Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial

Study acronym: PBM
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 2, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The development of an integral and global treatment to improve the quality of life in those withType II Diabetes Patients is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.
Trial Details
NCT Number NCT07047248
Lead Sponsor University of Malaga
Collaborators: clinical professor
Conditions Type II Diabetes Mellitus
Enrollment 44 participants
Start Date 2025-08-30
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-02